Dashboard
My Portfolio
Backtest
New
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Tikun Olam - Cannabit Pharma Ltd. (TKUN)
Market Closed
14 Oct, 03:25 PM
TASE
All
(2)
IL
(1)
US
(1)
TASE
Primary
OTC PINK
92,100.
00
ILA
+8,450
+10.1016%
ILA
1.67B
Market Cap
-
P/E Ratio
5,645,387.6%
Div Yield
2
Volume
0
Eps
83,650
ILA
Previous Close
Watching
Watch
Add Transaction
Day Range
83,650
92,100
Year Range
683
1,895,000
Want to track
TKUN
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
Tikun Olam - Cannabit Pharma Ltd. (TKUN) Statistics
Valuation metrics
Market Cap
1.67B
Enterprise value
11.68M
Trailing P/E (ttm)
-0
Forward P/E
-
PEG ratio
-0
Price/Sales (ttm)
0
Price/Book (mrq)
-0.14
Enterprise Value/Revenue
1.22
Enterprise Value/EBITDA
-0.6
Overview
Shares outstanding
84.96M
Float
478.67K
Shares short
-
% Held by insiders
0.4%
% Held by institutions
-
Average volume (10 days)
5
Average volume (90 days)
5.54K
Price summary
52-Week low
683
52-Week high
1,895,000
Beta
0.74
50-Day moving average
63,136.91
200-Day moving average
18,364.6
Dividends and splits
Forward annual dividend rate
5,645,387.6
Forward annual dividend yield
2,878.831%
Trailing annual dividend rate
1,411,346.9
Trailing annual dividend yield
719.7078%
5-Year annual dividend yield
-
Payout ratio
-
Dividend Date
-
Ex-Dividend Date
-
Last split factor
1:500
Last split Date
24 Aug 2026
Financials
Fiscal year
Fiscal year ends
31 Dec 2024
Most recent quarter (mrq)
31 Dec 2016
Profitability
Profit margin
-1.86%
Operating margin
-0.83%
Operational effectiveness
Return on assets
-12.27%
Return on equity
1.29%
Income Statement
Revenue (ttm)
34.95M
Revenue per share (ttm)
5.64
Quarterly revenue growth (yoy)
-0.35%
Gross profit (ttm)
-1.22M
EBITDA
-
Net income to common (ttm)
-40.1M
Diluted EPS (ttm)
-10.52
Quarterly earnings growth (yoy)
-
Balance Sheet
Total cash (mrq)
-
Total cash per share (mrq)
0
Total debt (mrq)
15.23M
Total Debt/Equity (mrq)
-0.77
Current ratio (mrq)
0.06%
Book value per share (mrq)
-13.5
Cash Flow
Cash flow statement
-31.15M
Levered free cash flow (LFCF)
-40.1M